The interferon-free regimen of ABT-@ with ritonavir ( ABT-@ / r ) , ombitasvir , and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic response in a phase @ study involving patients with hepatitis C virus ( HCV ) genotype @ infection .